Clinical Studies
Breast Care
Cardiology
Colon Cancer
Dermatology
Diabetes
Gastrointestinal
HIV/AIDS
Mental Health
Neurology
Obesity/Weight Management
Women's Health
Other
Special Features
Advances/Research
Mellitus Patients to Restore Pancreatic Cell Function
| Principal Investigator: | Agustin Busta, MD | |
| Time frame of study: | 1 year | |
| Time frame of participation: | 12 months | |
| Number of participants needed: | Open | |
| Location of Study: | Fierman Hall 317E. 17TH St. 7th Floor New York, NY 10003 |
|
| Contact Co-investigator | Bianca Alfonso,
MD |
Summary:
Subjects will be recruited from Beth Israel Medical Center
– Emergency Department and Medical Wards, from Endocrinology Faculty
Practice and General Medicine Clinic; we will advertise our study on Beth
Israel Medical Center’s website.
The study will include 80 adults, males and females, with newly diagnosed
type1 diabetes (time from diagnosis < 4weeks)
Subjects will be positive for at least one autoantibody to either glutamic
acid decarboxylase or islet cell.